Trulieve Cannabis Corp. (TRLV) Stock
Trulieve Cannabis stock price chart
TRLV stock quote & key statistics
Trulieve Cannabis annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $1.18B | -$116.4M | -$0.15 |
| FY2024 | $1.19B | -$155.1M | -$0.50 |
| FY2023 | $1.13B | -$526.8M | -$0.45 |
| FY2022 | $1.22B | -$246.1M | -$0.39 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Trulieve Cannabis Corp.
Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands.
The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.
Trulieve Cannabis stock FAQ
What is the Trulieve Cannabis stock ticker symbol?
Trulieve Cannabis Corp. trades on the NYSE under the ticker symbol TRLV.
What sector and industry is Trulieve Cannabis in?
Trulieve Cannabis Corp. is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.
How many employees does Trulieve Cannabis have?
Trulieve Cannabis Corp. has about 5,000 full-time employees.
What were Trulieve Cannabis's revenue and earnings last fiscal year?
Trulieve Cannabis reported revenue of $1.18B and net income of -$116.4M in fiscal 2025, with earnings per share of -$0.15. Revenue declined 0.4% from the prior year.
When did Trulieve Cannabis go public?
Trulieve Cannabis stock began trading on June 10, 2026.
Drug Manufacturers - Specialty & Generic stocks
All Healthcare stocks →- ALKSAlkermes
- AMPHAmphastar Pharmaceuticals
- AMRXAmneal Pharmaceuticals
- ANIPANI Pharmaceuticals
- BCRXBioCryst Pharmaceuticals
- COLLCollegium Pharmaceutical
- EBSEmergent BioSolutions
- ELANElanco Animal Health
- EOLSEvolus
- HIMSHims & Hers Health
- INDVIndivior
- IRWDIronwood Pharmaceuticals
- KNSAKiniksa Pharmaceuticals
- LNTHLantheus
- NBIXNeurocrine Biosciences
- ORGOOrganogenesis
- PAHCPhibro Animal Health
- PBHPrestige Consumer Healthcare
- PCRXPacira BioSciences
- PRGOPerrigo
- SUPNSupernus Pharmaceuticals
- UTHRUnited Therapeutics
- VTRSViatris
- ZTSZoetis